Cite
Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
MLA
Saito, Takao, et al. “Mizoribine Therapy Combined with Steroids and Mizoribine Blood Concentration Monitoring for Idiopathic Membranous Nephropathy with Steroid-Resistant Nephrotic Syndrome.” Clinical and Experimental Nephrology, vol. 21, no. 6, Dec. 2017, pp. 961–70. EBSCOhost, https://doi.org/10.1007/s10157-016-1340-2.
APA
Saito, T., Iwano, M., Matsumoto, K., Mitarai, T., Yokoyama, H., Yorioka, N., Nishi, S., Yoshimura, A., Sato, H., Ogahara, S., Sasatomi, Y., Kataoka, Y., Ueda, S., Koyama, A., Maruyama, S., Nangaku, M., Imai, E., Matsuo, S., & Tomino, Y. (2017). Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome. Clinical and Experimental Nephrology, 21(6), 961–970. https://doi.org/10.1007/s10157-016-1340-2
Chicago
Saito, Takao, Masayuki Iwano, Koichi Matsumoto, Tetsuya Mitarai, Hitoshi Yokoyama, Noriaki Yorioka, Shinichi Nishi, et al. 2017. “Mizoribine Therapy Combined with Steroids and Mizoribine Blood Concentration Monitoring for Idiopathic Membranous Nephropathy with Steroid-Resistant Nephrotic Syndrome.” Clinical and Experimental Nephrology 21 (6): 961–70. doi:10.1007/s10157-016-1340-2.